![Frontiers | Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis Frontiers | Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis](https://www.frontiersin.org/files/Articles/881202/fcdhc-03-881202-HTML-r1/image_m/fcdhc-03-881202-g002.jpg)
Frontiers | Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis
![Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014 Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014](https://journals.sagepub.com/cms/10.1177/0004563213518758/asset/images/large/10.1177_0004563213518758-fig1.jpeg)
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
![Serum Free Light Chain Concentration (>1000mg/dl) at Diagnosis and at Relapse Predicts for Very Poor Prognosis in Multiple Myeloma - ScienceDirect Serum Free Light Chain Concentration (>1000mg/dl) at Diagnosis and at Relapse Predicts for Very Poor Prognosis in Multiple Myeloma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000649711935699X-fx1.jpg)
Serum Free Light Chain Concentration (>1000mg/dl) at Diagnosis and at Relapse Predicts for Very Poor Prognosis in Multiple Myeloma - ScienceDirect
![Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial](https://www.mdpi.com/cancers/cancers-13-04856/article_deploy/html/images/cancers-13-04856-g001.png)
Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
![Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial](https://www.mdpi.com/cancers/cancers-13-04856/article_deploy/html/images/cancers-13-04856-g002.png)
Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
The changes of serum IgA, free kappa/lambda ratio, creatinine and free... | Download Scientific Diagram
![Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial](https://www.mdpi.com/cancers/cancers-13-04856/article_deploy/html/images/cancers-13-04856-g004.png)
Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
![The utility of MASS‐FIX to detect and monitor monoclonal proteins in the clinic - Milani - 2017 - American Journal of Hematology - Wiley Online Library The utility of MASS‐FIX to detect and monitor monoclonal proteins in the clinic - Milani - 2017 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d7cfdcb1-825f-4daa-8a5d-68023983e3f0/ajh24772-fig-0001-m.jpg)